readthroughSign in
CompanyRZLTNasdaqRedwood City, CA

Rezolute, Inc.

Rezolute develops ersodetug, an antibody therapy for refractory hypoglycemia caused by hyperinsulinism.

8-KNov 16Latest SEC filing
Nov 16Latest story